Pharmacist Explains - Rybelsus (the tablet version of Ozempic)

What are your thoughts on these GLP-1 analogue medications? Comment below!
Welcome back Long Gamers!
As you probably know, GLP-1 analogues such as Ozempic and Mounjaro have become widely used medications. Mainly for lowering blood sugar levels and treating type 2 diabetes, but also for reducing weight. But, these medications are injections, which may stop many people from wanting to try them.
It makes sense that trying to make them in a tablet form would be the goal, and that is exactly what researchers and manufacturers are trying to do. It seems that tablets are the future for these medications and so today, this will be my focus.
Expect to learn about
1. Rybelsus (the only tablet form of GLP-1 analogies currently available.
2. Why its so difficult to get tablets versions of these medications
3. How Rybelsus overcomes these difficulties
4. How the tablets compare to the injections (are they as effective?)
Hope you enjoy!
If you have any further questions regarding Rybelsus, or anything else, please comment or get in touch with me.
Don't forget to subscribe and give a like if you enjoyed the video. I will see you next week and until then, keep playing the long game.
____________________________________________________
*A little bit about me:
My name is Kamini, I have a bachelor of pharmacy with first class honours from Curtin University. I am currently working as a registered pharmacist, while completing a master of Nutrition. As I go through my work and studies, I am continuously learning new things and this channel is where I pass on my learnings and knowledge to anyone that is interested so that we can all play the long game that is health, together.
Send any questions/enquiries to [e-mail]
Follow me on Instagram for more!
@longgame_health

[@LloydHarwood]

Another great video!
Hopefully this means the shortage will be fixed and diabetics who need this medication will be able to access it

[@LongGameHealth]

Unfortunately, it’s probably still going to be a while before the shortages are solved. As more research is still needed before approvals for other uses and in other countries go through. But, eventually I am expecting more people to be on tablets instead of injections.